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Two spectrophotometric methods are described for the determination of isoniazid (INH) in pharmaceuticals. In the first method




medium and the resulting blue colored chromogen
measured at 760 nm. Iron(II), formed as a result of reaction between INH and iron(III), is made to react with ferricyanide, and the
resulting Prussian blue is measured at 760 nm, basing the second method (FFC method). The conditions for better performance
are optimized. Beer’s law is obeyed in the concentration ranges 0.5–10 and 0.2–3.0 𝜇g mL−1 for FCR method and FFC methods,
respectively, with corresponding molar absorptivity values of 1.12 × 104 and 4.55 × 104 L mol−1 cm−1. The methods are validated
for accuracy, precision, LOD, LOQ, robustness, and ruggedness as per the current ICH guidelines. The validated methods were
successfully applied to quantify INH in its commercial formulation with satisfactory results; hence the methods are suitable for
isoniazid determination in bulk drugs and pharmaceuticals.
1. Introduction
Isoniazid (INH) (Figure 1), chemically known as pyridine-
4-carboxylic acid hydrazide, is an antitubercular drug now
widely used together with rifampicin and streptomycin for
the chemotherapy of tuberculosis. This has prompted many
investigators to devise methods for its determination in its
pure form as well as in its tablet form.
The drug is official in Indian Pharmacopoeia (IP) [1],
British Pharmacopoeia (BP) [2], and United State Pharma-
copoeia (USP) [3]. IP and BP describe titration of the drug
with potassium bromate in presence of potassium bromide
using methyl red indicator. USP describes HPLC method
using L
1
column (4.6mm × 25 cm) and a mobile phase





) with a flow rate of 1.5mLmin−1 and UV-
detection at 254 nm. Apart from the above official methods,
a number of methods based on several techniques are
found in the literature for INH and include titrimetry [4–7],
voltammetry [8–13], ion selective electrode-potentiometry
[14–19], amperometry [20, 21], spectrofluorimetry [22, 23],
chemiluminescence spectrometry [24–33], high performance
liquid chromatography (HPLC) [34–37], gas chromatography
(GC) [38–40], LC/LC-MS [41], and capillary electrophoresis
[42–44].
Visible spectrophotometry is by far the most widely used
technique for the assay of INH. Methods were based on a
variety of reaction schemes such as nucleophilic substitu-
tion [45], condensation [46–49], charge-transfer and ion-
pair [50], derivatization [51–54], diazo-coupling [55, 56],
oxidative coupling [57, 58], complex formation [59–61], and
redox followed by complexation [62–65]. These methods
suffer from one or more of the disadvantages such as dras-
tic experimental conditions, use of organic solvent, longer
standing time, poor sensitivity, and narrow linear range.
Folin-Ciocalteu (F-C) reagent or iron(III) and ferricyanide
have been widely used for the sensitive determination of
a wide-ranging phenolic and amine organic compounds of
pharmaceutical importance [66–74].
The aim of this work was to investigate the utility of F-C
reagent and iron(III) and ferricyanide systems in the assay
of INH. The methods had sufficiently good accuracy and
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Figure 1: Structure of INH.
2. Experimental
2.1. Apparatus. A Systronics model 166 digital spectropho-
tometer (Ahmedabad, India) with matched 1-cm quartz cells
was used for absorbance measurements.
3. Materials
Chemicals used were of analytical reagent grade. Distilled
water was used throughout the investigation. Pharmaceutical
grade INH certified to be 99.85% pure was kindly provided
by Cipla India Ltd., Bangalore, India, and was used as
received. Isokin-300 (Pfizer Ltd., Gandhinagar, Hyderabad,
India) tablets containing isoniazid 300mg with vitamin B
6
10mg were purchased from local commercial store.
3.1. Reagents
3.1.1. Folin-Ciocalteu Reagent. Aqueous solution of Folin-
Ciocalteu reagent (1 : 1 v/v) was prepared by mixing 50mL of
reagent (Merck, Mumbai, India) with 50mL water.
3.1.2. Sodium Carbonate. A 20% solution of sodium carbon-
ate was prepared by dissolving 20 g compound (S.D. Fine
Chem. Ltd., Mumbai, India) in 100mL water.
3.1.3. Potassium Ferricyanide. A 500 𝜇gmL−1 potassium fer-
ricyanide solution was prepared by dissolving 50mg reagent
(Glaxo Laboratory, Mumbai, India) in 100mL water.
3.1.4. Ferric Chloride (FeCl
3





O was prepared by dissolving 14 g of the chemical
(S.D. Fine Chem. Ltd., Mumbai, India) in 100mL of 0.1M
HCl (Merck, Mumbai, India).
3.1.5. Standard Drug Solution. A stock standard solution of
INH (100𝜇gmL−1) was prepared by dissolving 10mg of pure
INH in 100mL water, appropriately diluted to 20𝜇gmL−1
INH for method A and 10 𝜇gmL−1 INH for method B with
water, and used in the assay.
4. Assay Procedure
4.1. Method A (FCR Method). Into a series of 10mL vol-
umetric flasks, different aliquots of working standard INH
solution (20𝜇gmL−1) ranging from 0.25 to 5.0mL equivalent
to 0.5–10.0 𝜇gmL−1 were transferred and the total volume
was brought to 5mL with water. To each flask, 2mL of





successively added by means of a microburette. The flasks
were stoppered and the contents were mixed well and kept
at room temperature for 10min. The volume was made up
to the mark with water and the absorbance of each solution
was measured at 760 nm against a reagent blank similarly
prepared in the absence of INH.
4.2. Method B (FFC Method). Different aliquots of standard
INH solution (10 𝜇gmL−1) ranging from 0.2 to 3.0mL were
transferred into a series of 10mL of calibrated flasks and
the total volume was brought to 3mL with water. Then,
1.5mL of 500𝜇gmL−1 potassium ferricyanide and 1.0mL
FeCl
3
solution were accurately added. The volume was made
up to the mark with water, content mixed, and the flasks
were kept at room temperature. After 10min, the absorbance
was measured at 760 nm against reagent blank prepared
simultaneously without adding INH.
Standard graph was prepared by plotting the absorbance
versus INH concentration, and the concentration of the
unknown was computed from the respective regression
equation derived using the absorbance-concentration data.
4.3. Procedure for Pharmaceutical Tablets. Twenty tablets
were weighed and ground into a fine powder. An accurately
weighed quantity containing 10mg of INHwas transferred to
a 100mL volumetric flask, 60mL water added, shaken well
for 20 minutes and made up to mark with water, and then
filtered.This solution was diluted to a 20 and 10 𝜇gmL−1 INH
with water and analyzed by the recommended procedures.
4.4. Procedure for Placebo Blank and Synthetic Mixture
Analyses. A placebo blank containing starch (10mg), acacia
(15mg), hydroxyl cellulose (10mg), sodium citrate (10mg),
talc (20mg), magnesium stearate (15mg), and sodium algi-
nate (10mg) was prepared by mixing all components into
a homogeneous mixture. 10mg of the placebo blank was
accurately weighed and its solutionwas prepared as described
under Procedure for Pharmaceutical Tablets and then sub-
jected to analysis by following the general procedure.
An accurately weighed 10mg of INH was added to 10mg
of placebo blank and homogenized. Synthetic mixture was
quantitatively transferred into a 100mL volumetric flask and
the extract was prepared as described under the Procedure
for Pharmaceutical Tablets. The resulting extract was diluted
to get 20 and 10 𝜇gmL−1 INH solutions, respectively. Suitable
aliquot of the solution was analyzed at three levels by
following the general assay procedure.
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solution andB: blank. (b) Absorption
spectra for method B, reaction product of INH (1.25 𝜇gmL−1) with ferric chloride and ferricyanide solution (-󳵳-) and blank (-Î§-).
5. Validation of Method
The method was validated according to the procedures
described in ICH guidelines [75] for the validation of ana-
lytical methods.
Limits of Detection (LOD) and Quantification (LOQ). The
limits of detection (LOD) and quantification (LOQ)were cal-
culated according to the ICH guidelines using the formulae:
LOD = 3.3𝑆
𝑏




where 𝑆 is the standard deviation of blank absorbance values
and 𝑏 is the slope of the calibration plot.
5.1. Precision and Accuracy. The intraday precision was eval-
uated by analyzing INH solution at three different levels. Sim-
ilarly the interday precision was evaluated on five consecutive
days (𝑛 = 5). In each case and for each concentration, mean
value of the INH found and the relative standard deviations
(RSD) were calculated. The accuracy of the methods was
determined by the percent mean deviation between the
obtained and known concentration of INH.
5.2. Robustness and Ruggedness. Method robustness was
studied by making small changes in the optimized experi-
mental variables and their effect on the absorbance was eval-
uated by calculating the percentage RSD values. In order to
determine the method ruggedness, analyses were performed
using three instruments and also by three analysts with the
same instrument.
6. Results and Discussion
The proposed FCR method is based on the formation of a
blue colored chromogen, following the reduction of phos-
phomolybdotungstic mixed acid of the F-C reagent [73] by
INH in the presence of sodium carbonate, which could be
measured at 760 nm. The mixed acids in the F-C reagent
Table 1: Sensitivity and regression parameters.
Parameter Method A Method B
𝜆max, nm 760 760
Color stability, min 60 90
Linear range, 𝜇gmL−1 0.5–10.0 0.2–3.0
Molar absorptivity (𝜀), Lmol−1 cm−1 1.12 × 104 4.55 × 104
Sandell sensitivity∗, 𝜇g cm−2 0.0123 0.003
Limit of detection (LOD), 𝜇gmL−1 0.03 0.14
Limit of quantification (LOQ), 𝜇gmL−1 0.09 0.42
Regression equation, 𝑌∗∗
Intercept (𝑎) 0.0131 0.0198
Slope (𝑏) 0.0905 0.3176
Standard deviation of 𝑎 (𝑆
𝑎
) 9.98 × 10−2 9.98 × 10−2
Standard deviation of 𝑏 (𝑆
𝑏
) 1.24 × 10−2 3.98 × 10−2
Regression coefficient (𝑟) 0.9971 0.9979
∗Limit of determination as the weight in 𝜇gmL−1 of solution, which
corresponds to an absorbance of A = 0.001 measured in a cuvette of cross-
sectional area 1 cm2 and 𝑙 = 1 cm.
∗∗
𝑌 = 𝑎 + 𝑏𝑋, where 𝑌 is the absorbance,𝑋 is concentration in 𝜇gmL−1, 𝑎
is intercept, and 𝑏 is slope.





























INH probably affects reduction of oxygen atoms from
tungstate and/or molybdate in the F-C reagent by producing
one or more possible reduced species which have character-
istic intense blue color.
The FFCmethod involves the redox reaction of INHwith
ferric chloride, in the presence of potassium ferricyanide,
under mild acidic conditions, to produce a blue colour with
maximum absorption at 760 nm. The first step in the colour
development is the reduction of iron(III) of ferric chloride to
iron(II) which subsequently reacts with ferricyanide to form
Prussian blue.
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Figure 3: (a) Effect of volumes of F-C reagent (1 : 1) on the reaction




solution for method A.




on color formation (6𝜇gmL−1 INH) for
method A. (c) Reaction time and stability of colored species for
method A (6𝜇gmL−1 INH).
7. Method Development
7.1. Spectral Characteristics. The intensely blue colored prod-
uct (molybdenum-tungsten mixed acid blue in FCR method
and Prussian blue in FFC method) formed in both methods
exhibited maximum absorption at 760 nm. The absorption
spectra of the blue colored products and of the reagent blanks
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Figure 4: (a) Effect of volume of FeCl
3
for method B (1.5 𝜇gmL−1
INH). (b) Effect of volume of ferricyanide formethod B (1.5𝜇gmL−1
INH). (c) Reaction time and stability of colored species for method
B (1.5 𝜇gmL−1 INH).
7.2. Optimization of Experimental Variables. A series of
preliminary experiments necessary for rapid and quantitative
formation of colored products to achieve the maximum
stability and sensitivity were performed. Optimum condition
was achieved by varying one parameter at a time while
keeping other parameters constant and observing its effect on
the absorbance at 760 nm.
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Table 2: Evaluation of intraday and interday accuracy and precision.
Method
INH Taken (𝜇gmL−1) Intraday accuracy and precision (𝑛 = 7) Interday accuracy and precision (𝑛 = 5)











3.0 2.96 1.24 0.89 3.07 2.34 2.12
6.0 6.11 1.84 1.03 6.12 2.00 2.53
9.0 9.14 1.56 1.52 9.15 1.67 2.00
B
1.0 1.01 1.02 1.92 1.03 3.00 1.85
1.5 1.47 2.01 1.15 1.54 2.67 1.27
2.0 2.04 1.92 1.47 2.05 2.50 1.62
aMean value of 7 determinations; brelative standard deviation (%); crelative error (%).














3.0 1.45 1.69 — 2.20 2.32
6.0 1.72 1.35 — 1.74 1.92
9.0 2.10 1.71 — 2.44 2.57
B
1.0 1.72 — 1.59 1.78 2.12
1.5 1.84 — 1.61 2.11 1.62
2.0 2.12 — 1.72 1.07 2.54
∗Reaction times were 10 ± 2min for both methods. #Volumes of FC regent added were 2 ± 0.2mL for method A; volumes of ferricyanide added were 1.5 ±
0.1mL for method B.
7.3. Optimization for FCR Method
7.3.1. Effect of Concentration of F-C Reagent. Several experi-
ments were carried out to study the influence of F-C reagent
concentration on the color development and the obtained
results are shown in Figure 3(a). It is apparent that 1.0 to
5.0mL of reagent gave the maximum color intensity; thus
3.0mL of reagent was used throughout the investigation.
7.3.2. Selection of Reaction Medium and Optimization of the
Base. To select a suitable medium for the reaction, different
aqueous bases such as sodium hydroxide, sodium carbon-
ate or bicarbonate, sodium acetate, and sodium hydrogen
phosphate were investigated. Better results were obtained









solution (0–5mL)were attempted at a constant concentration
of INH (6 𝜇gmL−1) and the results of the observation are
shown in Figure 3. It was found that different volumes rang-





2.0mL was used throughout the work (given in Figure 3(b)).
Maximum color development was obtained in 10min
after mixing the reactants, and the color was stable for at
least 60min thereafter (Figure 3(c)). The sequence of order
of addition of the reactants had significant effect on the
absorbance value. So, the order used in the general procedure
should be followed for maximum absorbance.
7.4. Optimization for FFC Method. To optimize the concen-
trations of ferricyanide and ferric chloride reagents, different
volumes of these reagents were used with a fixed concentra-
tion of INH. Constant absorbance was found with 1.0mL of
0.5MFeCl
3
and 1.5mLof 500𝜇gmL−1 ferricyanide solutions,
as shown in Figures 4(a) and 4(b).
Colour development was complete in 10min and stable
for the next 90min (Figure 4(c)). Different results were
obtained when different order of addition of reactants was
followed. The order of addition of reactants followed in the
recommended procedure resulted in rapid color formation
with maximum sensitivity and stability.
8. Method Validation
8.1. Linearity, Sensitivity, Limits of Detection, and Quantifi-
cation. A linear correlation was found between absorbance
at 𝜆max and concentration of INH in the ranges given in
Table 1. Regression analysis of the Beer’s law data using the
method of least squares was made to evaluate the slope (𝑏),
intercept (𝑎), and correlation coefficient (𝑟) for each system
and the analytical results obtained from these investigations
are presented in Table 1. The optical characteristics such as
Beer’s law limits, molar absorptivity, and Sandell sensitivity
values are also given in Table 1. The high values of 𝜀 and
low values of Sandell sensitivity and LOD indicate the high
sensitivity of the proposed methods.
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Table 4: Results of analysis of tablets by the proposed methods.
Tablets analyzed Label claim (mg/tablet)
Found∗ (percent of label claim ± SD)
Official method Proposed methods
Method A Method B
Iskin-300 300 99.86 ± 1.36
101.5 ± 1.16 101.2 ± 0.92
𝑡 = 2.06 𝑡 = 1.83
𝐹 = 1.37 𝐹 = 2.19
∗Mean value of five determinations.
Tabulated 𝑡-value at the 95% confidence level is 2.77.
Tabulated 𝐹-value at the 95% confidence level is 6.39.
Table 5: Results of recovery study via standard addition method with tablet.




2.96 1.5 4.41 99.28 ± 2.03
2.96 3.0 6.01 100.9 ± 3.12
2.96 4.5 7.56 101.3 ± 2.99
B Isokin-300
1.01 0.5 1.51 99.85 ± 2.25
1.01 1.0 2.04 101.3 ± 2.32
1.01 1.5 2.55 101.7 ± 3.14
∗Mean value of three determinations.
8.2. Intraday and Interday Precision and Accuracy. The pre-
cision and accuracy of the proposed method were studied
by repeating the experiment seven times within the day
to determine the repeatability (intraday precision) and five
times on different days to determine the intermediate preci-
sion (interday precision). The assay was performed for three
levels of analyte in this method. The results of this study
are summarized in Table 2. The percentage relative standard
deviation (%RSD) values were ≤2.01% (intraday) and ≤3.00%
(interday) indicating good precision of themethod. Accuracy
was evaluated as percentage relative error (%RE) between the
measured mean concentrations and taken concentrations of
INH, and it was ≤2.53% demonstrating the high accuracy of
the proposed method.
8.3. Selectivity. A selective study was performed to determine
the effect of matrix on the absorbance by analyzing the
placebo blank. In the analysis of placebo blank solution the
absorbance in each case was equal to the absorbance of
blank which revealed no interference. To assess the role of
the inactive ingredients on the assay of INH, the general
procedure was applied on the synthetic mixture extract by
taking three different concentrations of INHwithin the range.
The percentage recovery values were in the range 96.3–
102.3% and 95.4–101.8% with RSD <4% indicating clearly the
noninterference from the inactive ingredients in the assay of
INH.
8.4. Robustness and Ruggedness. The robustness of the
method was evaluated by making small incremental changes
in the volume of reagent and reaction time, and the effects
of the changes were studied by measuring the absorbance of
the colored product. The changes had negligible influence
on the results as revealed by small intermediate precision
values expressed as %RSD (≤2.54%). Method ruggedness
was demonstrated having the analysis done by three analysts
and also by a single analyst performing analysis on three
different instruments in the same laboratory. Intermediate
precision values (%RSD) in both instances indicated accept-
able ruggedness. These results are presented in Table 3.
8.5. Application to Tablets. The proposed methods were
applied to the quantification of INH in commercial tablets.
The tablets were assayed by the official BP method [2], which
describes titration of the drug with potassium bromate in
presence of potassium bromide using methyl red indicator.
The results obtained by the proposed methods agree well
with the claim and also are in agreement with those of the
official method. Statistical analysis of the results did not
detect any significant difference between the performance of
the proposed method and reference method with respect to
accuracy and precision as revealed by the Student’s 𝑡-value
and variance ratio 𝐹-value. The results of assay are given in
Table 4.
8.6. Recovery Study. To further assess the accuracy of the
method, recovery experiment was performed by applying the
standard-addition technique. The recovery was assessed by
determining the agreement between the measured standard
concentration and added known concentration to the sample.
The test was done by spiking the preanalyzed tablet INHwith
pure INH at three different levels (50, 100, and 150%) of the
content present in the preparation and the total was found by
the proposedmethod. Each test was repeated three times.The
recovery percentage values ranged between 99.28 and 101.7%
with standard deviation in the range 0.99–1.32%. Closeness
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of the results to 100% showed the fairly good accuracy of the
method. The results are shown in Table 5.
9. Conclusion
Two simple, rapid, selective, and sensitive methods have
been proposed for the assay of INH in bulk drugs and in
tablets. The methods are based on the well-characterized and
established redox and complexation reactions and use very
common and inexpensive chemicals and easily accessible
instrument. The procedures described here are easily carried
out and much simpler than the reported methods for INH
(Table 6) but have been demonstrated to be more sensitive
in terms of linear dynamic range and sensitivity parameters.
The methods were applied successfully to the assay of INH
in tablets without interferences from the common excipients.
The proposed methods are suitable for isoniazid determina-
tion in bulk drug and pharmaceuticals; hence these methods
can be used in quality control laboratories.
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